Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 131Lymphoma 117Lymphoma, Large B-Cell, Diffuse 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Multiple Myeloma 50Lymphoma, Non-Hodgkin 46Lymphoma, Follicular 45Leukemia 39Hodgkin Disease 33Lymphoma, Mantle-Cell 32Burkitt Lymphoma 32Lymphoma, Large-Cell, Immunoblastic 21Lymphoma, Large-Cell, Anaplastic 20Lymphoma, B-Cell, Marginal Zone 19Neoplasm Metastasis 16Leukemia, Lymphocytic, Chronic, B-Cell 16Neoplasms, Plasma Cell 15Neoplasms 13Lymphoma, T-Cell, Peripheral 10Dendritic Cell Sarcoma, Interdigitating 10Recurrence 9Lymphoma, B-Cell 9Primary Myelofibrosis 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Blast Crisis 7Lymphoma, T-Cell 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Prostate Cancer Metastatic 5

Interventions

tofacitinib 6ibrutinib 6Imatinib Mesylate 5ofatumumab 4Rituximab 4nilotinib 3ruxolitinib 2bosutinib 2asciminib 2Pentostatin 2Oxycodone 2Naloxone 2KW-2478 2Dasatinib 2ziconotide 1sodium luminolate 1posaconazole 1pegfilgrastim 1oblimersen 1obinutuzumab 1montelukast 1mocetinostat 1lonafarnib 1ixekizumab 1fludarabine 1fenebrutinib 1canakinumab 1baricitinib 1abexinostat 1Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bronchiolitis Obliterans Syndrome × Prednisone × Clear all
NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡